Skip to main content
. 2020 Apr 29;2020:7026530. doi: 10.1155/2020/7026530

Table 3.

Crude and adjusted linear regression coefficients and 95% confidence intervals for changes in LDL.

Variable Change in LDL
Crude model Simple interaction model Fully adjusted model
β 95% CI β 95% CI β 95% CI
Intercept NA NA 0.159 (-0.041, 0.349) 0.804 (-0.623, 2.232)
Atorvastatin use (yes) Reference Reference Reference Reference Reference Reference
Rosuvastatin use (yes) 0.002 (-0.113, 0.118) -0.179 (-0.449, 0.089) -0.518 (-0.902, -0.134)
Average exercise minutes/week (minutes) -0.0004 (-0.001, 0.001) -0.001 (-0.002, 0.001) -0.002 (-0.004, -0.001)
Rosuvastatin use
Average exercise interaction
NA NA 0.001 (-0.001, 0.003) 0.004 (0.001, 0.007)
Age (years) 0.0001 (-0.006, 0.006) NA NA 0.005 (-0.006, 0.015)
Sex (male) 0.074 (-0.043, 0.191) NA NA 0.275 (0.057, 0.493)
Tobacco smoking (previous/current smoker) 0.004 (-0.094, 0.101) NA NA 0.003 (-0.161, 0.167)
Other cholesterol-lowering medications (yes) 0.033 (-0.167, 0.233) NA NA 0.099 (-0.197, 0.396)
Anticoagulants (yes) 0.031 (-0.134, 0.197) NA NA -0.205 (-0.548, 0.138)
Antiplatelets (yes) 0.099 (-0.065, 0.264) NA NA -0.124 (-0.430, 0.182)
Cardiovascular medications (yes) -0.033 (-0.269, 0.204) NA NA -0.079 (-0.371, 0.214)
Oral antidiabetics (yes) 0.005 (-0.128, 0.138) NA NA 0.049 (-0.144, 0.241)
Insulin (yes) -0.025 (-0.275, 0.226) NA NA -0.245 (-0.599, 0.109)
Adherence (%) to exercise schedule (weekly sessions performed/prescribed) -0.002 (-0.005, 0.002) NA NA 0.001 (-0.005, 0.005)
Weight (kg) 0.001 (-0.002, 0.004) NA NA -0.002 (-0.007, 0.003)
Systolic BP (mmHg) 0.001 (-0.002, 0.005) NA NA -0.005 (-0.012, 0.002)
Diastolic BP (mmHg) 0.004 (-0.001, 0.010) NA NA 0.008 (-0.003, 0.018)
6MWT at admission (meters) -0.001 (-0.001, 0.0001) NA NA -0.001 (-0.002, -0.0001)

6MWT: 6-minute walk test; LDL: low-density lipoprotein; HDL: high-density lipoprotein; BP: blood pressure.